G01N 2333/72
For hormones
Official title: for hormones
G01N2333/72 (For hormones) appears on 994 US grants and 1,736 published applications in this corpus.
Search patents in G01N- Granted patents
- 994
- Published applications
- 1,736
- Assignees
- 729
- Inventors
- 3,284
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 6 | 0 |
| 1997 | 10 | 0 |
| 1998 | 19 | 0 |
| 1999 | 21 | 0 |
| 2000 | 13 | 0 |
| 2001 | 33 | 14 |
| 2002 | 30 | 50 |
| 2003 | 23 | 113 |
| 2004 | 21 | 92 |
| 2005 | 21 | 95 |
| 2006 | 38 | 103 |
| 2007 | 38 | 109 |
| 2008 | 47 | 88 |
| 2009 | 30 | 119 |
| 2010 | 65 | 91 |
| 2011 | 72 | 76 |
| 2012 | 50 | 52 |
| 2013 | 37 | 55 |
| 2014 | 47 | 58 |
| 2015 | 48 | 78 |
| 2016 | 32 | 84 |
| 2017 | 41 | 58 |
| 2018 | 42 | 71 |
| 2019 | 42 | 53 |
| 2020 | 26 | 51 |
| 2021 | 26 | 47 |
| 2022 | 25 | 52 |
| 2023 | 17 | 33 |
| 2024 | 22 | 40 |
| 2025 | 16 | 24 |
| 2026 | 21 | 30 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Anti-human neurotensin receptor 1 antibody and use thereof18 Aug 2026US 12,710,427 B2National Health Research Institutes
- Compositions and methods for detecting autoantibodies14 Jul 2026US 12,681,016 B2Ortho-Clinical Diagnostics, Inc.
- Method and system for determining intracellular mediators' activity9 Jun 2026US 12,650,424 B2Ecole Polytechnique Federale De Lausanne (Epfl)
- Screening methods using canine T2R receptors and pet food products and compositions identified using the same26 May 2026US 12,638,438 B2Mars, Incorporated
- Fluid transfer devices with integrated flow-based assay and methods of using the same26 May 2026US 12,638,445 B2Magnolia Medical Technologies, Inc.
- Growth hormone targeting polypeptides1 Oct 2026US 2026/0297205 A1The University of Chicago
- Anti-gprc5d nanobody and use thereof24 Sep 2026US 2026/0285971 A1Shandong Simcere Biopharmaceutical Co., Ltd.
- Antibody binding to thyroid-stimulating hormone receptor and use thereof24 Sep 2026US 2026/0285991 A1Shanghai Scizeng Medical Technology Co., Ltd.
- Prolactin Receptor Antibody and Use Thereof24 Sep 2026US 2026/0285993 A1
- Probe and Method for Detecting Membrane-Associated Molecules in Living Cells17 Sep 2026US 2026/0276629 A1
Most cited
By later US patents
- Methods of activating a melanocortin-4 receptor pathway in obese subjects277US 8,476,227 B2Ethicon Endo-Surgery, Inc. · 2013
- Methods for analyzing protein binding events132US 6,566,079 B2Signature BioScience, Inc. · 2003
- Methods for screening for binding partners of G-protein coupled receptors103US 9,260,505 B2Heptares Therapeutics Limited · 2016
- Methods of assaying receptor activity and constructs useful in such methods98US 5,891,646 ADuke University · 1999
- Methods of assaying receptor activity and constructs useful in such methods85US 6,110,693 ADuke University · 2000